52 related articles for article (PubMed ID: 28825917)
1. Evaluation of an automatic MR-based gold fiducial marker localisation method for MR-only prostate radiotherapy.
Maspero M; van den Berg CAT; Zijlstra F; Sikkes GG; de Boer HCJ; Meijer GJ; Kerkmeijer LGW; Viergever MA; Lagendijk JJW; Seevinck PR
Phys Med Biol; 2017 Oct; 62(20):7981-8002. PubMed ID: 28825917
[TBL] [Abstract][Full Text] [Related]
2. Fiducial marker guided prostate radiotherapy: a review.
O'Neill AG; Jain S; Hounsell AR; O'Sullivan JM
Br J Radiol; 2016 Dec; 89(1068):20160296. PubMed ID: 27585736
[TBL] [Abstract][Full Text] [Related]
3. Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation.
Patel D; Tan A; Brown A; Pain T
J Med Radiat Sci; 2020 Dec; 67(4):302-309. PubMed ID: 32614152
[TBL] [Abstract][Full Text] [Related]
4. Patient perceptions and preferences about prostate fiducial markers and ultrasound motion monitoring procedures in radiation therapy treatment.
Brown A; Pain T; Preston R
J Med Radiat Sci; 2021 Mar; 68(1):37-43. PubMed ID: 32997897
[TBL] [Abstract][Full Text] [Related]
5. [A review on the application of image fusion technology in prostate cancer radiotherapy based on gold fiducial biomarker].
Zhao JC; Tian L
Zhonghua Nan Ke Xue; 2023 Dec; 29(12):1038-1042. PubMed ID: 38639959
[TBL] [Abstract][Full Text] [Related]
6. Clinical experience and workflow challenges with magnetic resonance-only radiation therapy simulation and planning for prostate cancer.
Tyagi N; Zelefsky MJ; Wibmer A; Zakian K; Burleson S; Happersett L; Halkola A; Kadbi M; Hunt M
Phys Imaging Radiat Oncol; 2020 Oct; 16():43-49. PubMed ID: 33134566
[TBL] [Abstract][Full Text] [Related]
7. A Printer Indexing System for Color Calibration with Applications in Dietary Assessment.
Fang S; Liu C; Zhu F; Boushey C; Delp E
New Trends Image Anal Process ICIAP 2015 Workshops (2015); 2015 Sep; 9281():358-365. PubMed ID: 28573259
[TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy in oligometastatic prostate cancer.
Mandel P; Steuber T; Graefen M
Curr Opin Urol; 2017 Nov; 27(6):572-579. PubMed ID: 28825924
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy for metastatic prostate cancer: immuno-cold or the tip of the iceberg?
Laccetti AL; Subudhi SK
Curr Opin Urol; 2017 Nov; 27(6):566-571. PubMed ID: 28825923
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification in oligometastatic prostate cancer: where are we and what do we need?
Morgans AK; Hussain M
Curr Opin Urol; 2017 Nov; 27(6):547-552. PubMed ID: 28825922
[TBL] [Abstract][Full Text] [Related]
11. MR-OPERA: A Multicenter/Multivendor Validation of Magnetic Resonance Imaging-Only Prostate Treatment Planning Using Synthetic Computed Tomography Images.
Persson E; Gustafsson C; Nordström F; Sohlin M; Gunnlaugsson A; Petruson K; Rintelä N; Hed K; Blomqvist L; Zackrisson B; Nyholm T; Olsson LE; Siversson C; Jonsson J
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):692-700. PubMed ID: 28843375
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and safety of focal irreversible electroporation as salvage treatment for localized radio-recurrent prostate cancer.
Scheltema MJ; van den Bos W; Siriwardana AR; Kalsbeek AMF; Thompson JE; Ting F; Böhm M; Haynes AM; Shnier R; Delprado W; Stricker PD
BJU Int; 2017 Nov; 120 Suppl 3():51-58. PubMed ID: 28834167
[TBL] [Abstract][Full Text] [Related]
13. Are cone beam CT image matching skills transferrable from planning CT to planning MRI for MR-only prostate radiotherapy?
Brooks RL; McCallum HM; Pearson RA; Pilling K; Wyatt J
Br J Radiol; 2021 Jul; 94(1123):20210146. PubMed ID: 33914617
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers.
Goudschaal K; Beeksma F; Boon M; Bijveld M; Visser J; Hinnen K; van Kesteren Z
Radiat Oncol; 2021 Feb; 16(1):37. PubMed ID: 33608008
[TBL] [Abstract][Full Text] [Related]
15. MR-PROTECT: Clinical feasibility of a prostate MRI-only radiotherapy treatment workflow and investigation of acceptance criteria.
Persson E; Jamtheim Gustafsson C; Ambolt P; Engelholm S; Ceberg S; Bäck S; Olsson LE; Gunnlaugsson A
Radiat Oncol; 2020 Apr; 15(1):77. PubMed ID: 32272943
[TBL] [Abstract][Full Text] [Related]
16. A Multi-center Prospective Study for Implementation of an MRI-Only Prostate Treatment Planning Workflow.
Greer P; Martin J; Sidhom M; Hunter P; Pichler P; Choi JH; Best L; Smart J; Young T; Jameson M; Afinidad T; Wratten C; Denham J; Holloway L; Sridharan S; Rai R; Liney G; Raniga P; Dowling J
Front Oncol; 2019; 9():826. PubMed ID: 31555587
[No Abstract] [Full Text] [Related]
17. The rationale for MR-only treatment planning for external radiotherapy.
Jonsson J; Nyholm T; Söderkvist K
Clin Transl Radiat Oncol; 2019 Sep; 18():60-65. PubMed ID: 31341977
[TBL] [Abstract][Full Text] [Related]
18. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
[TBL] [Abstract][Full Text] [Related]
19. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
